Athina Ganner

Current Position

Attending Physician

Academic Education

1997 - 2004

Studies in Medicine, Medical University of Vienna and Charité, Universitätsmedizin Berlin

Advanced Qualifications

2012	Board Certification (Facharztprüfung) in Nephrology
2012	Doctoral degree in Medicine (Dr. med.)(summa cum laude), University of Freiburg, Advisor: Prof. Dr. Gerd Walz
2010	Board Certification (Facharztprüfung) in Internal Medicine
2009	Certification (Zusatzweiterbildung) in Emergency Medicine

Postgraduate Positions

2016 - present	Attending Physician (Funktionsoberärztin), Department of Medicine, Renal Division, Medical Center - University of Freiburg
2019 – 2021	Brigitte-Schlieben-Lange-Fellowship (Ministerium für Wissenschaft, Forschung und Kunst des Landes Baden-Württemberg)
2014 - 2016	Attending Physician, Department of Medicine and Department of Emergency Medicine, Triemli Hospital, Zürich
2012 - 2014	Attending Physician (Funktionsoberärztin), Department of Medicine, Renal Division, Medical Center - University of Freiburg
2011 - 2012	Attending Physician (Funktionsoberärztin), University Emergency Center - University of Freiburg
2004 - 2011	Research Fellow and Clinical Fellow, Renal Division, Medical Center - University of Freiburg

Link to all publications of Athina Ganner: PubMed

Publications on CRC 1453 funding

Pilz JF, Klein M, Neumann-Haefelin E, Ganner A. VHL-dependence of EHHADH Expression in a Human Renal Cell Carcinoma Cell Line. J Kidney Cancer VHL (2024). Mohl DA, Lagies S, Zodel K, Zumkeller M, Peighambari A, Ganner A, Plattner DA, Neumann-Haefelin E, Adlesic M, Frew IJ, Kammerer B. Integrated Metabolomic and Transcriptomic Analysis of Modified Nucleosides for Biomarker Discovery in Clear Cell Renal Cell Carcinoma. Cells (2023). Ganner A, Philipp A, Lagies S, Wingendorf L, Wang L, Pilz F, Welte T, …, Frew IJ, Walz G, Neumann-Haefelin E. SCD5 Regulation by VHL Affects Cell Proliferation and Lipid Homeostasis in ccRCC. Cells (2023). Welte T, Arnold F, Westermann L, Rottmann FA, Hug MJ, Neumann-Haefelin E, Ganner A. Eculizumab as a treatment for C3 glomerulopathy: a single-center retrospective study. BMC Nephrol (2023). Ganner A, Gehrke C, Klein M, Thegtmeier L, Matulenski T, …, Walz G, Frew IJ, Neumann-Haefelin E. VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma. Sci Rep (2021).